OMGEVI

EUIPO EUIPO 2020 Trademark registered

Protect this trademark from copycats!

With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.

The Union trademark OMGEVI was filed as Word mark on 07/08/2020 at the European Union Intellectual Property Office.
It was registered as a trademark on 11/24/2020. The current status of the mark is "Trademark registered".

Trademark Details Last update: February 9, 2024

Trademark form Word mark
File reference 018269844
Application date July 8, 2020
Publication date August 14, 2020
Entry date November 24, 2020
Expiration date July 8, 2030

Trademark owner

10 Earlsfort Terrace
D02 T380 Dublin 2
IE

Trademark representatives

5, boulevard de la Madeleine 75001 Paris FR

goods and services

5 Pharmaceuticals, medical and veterinary preparations; diagnostic preparations and materials; pharmaceuticals and natural remedies; pharmaceutical products for treatment of human diseases of the autonomic, respiratory, endocrine, circulatory, gastrointestinal, genito-urinary, integumentary, immune and central nervous system; pharmaceutical preparations for the treatment of cancer and pain; pharmaceutical preparations and substances for the treatment of respiratory diseases and disorders; pharmaceutical preparations and substances for the treatment of gastrointestinal diseases and disorders; pharmaceutical preparations and substances for the treatment of ocular and dermatological diseases and disorders; pharmaceutical preparations and substances for the treatment of neurogenic orthostatic hypotension and for the prevention and treatment of low blood pressure; pharmaceutical preparations and substances in the nature of anti-hypotensive and vasopressor agents; pharmaceutical preparations and substances for the treatment of Parkinson's disease and disorders; pharmaceutical preparations and substances for the prevention and treatment of dizziness and lightheadedness; pharmaceutical preparations and substances for the treatment of disorders characterized by a deficiency of norepinephrine; pharmaceutical preparations and substances for the treatment of bacterial and viral infections, namely anti-infectives

Trademark history

Date Document number Area Entry
May 24, 2023 Transfer / Change of address, Published
December 9, 2020 Change Representative, Published

ID: 11018269844